PubMed:11271907 JSONTXT

{"project":"PubCasesHPO","denotations":[{"id":"AB1","span":{"begin":83,"end":94},"obj":"HP:0012819"},{"id":"TI1","span":{"begin":19,"end":30},"obj":"HP:0012819"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-experiment","denotations":[{"id":"T1","span":{"begin":6,"end":18},"obj":"Disease"},{"id":"T2","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T3","span":{"begin":19,"end":30},"obj":"Disease"},{"id":"T4","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T5","span":{"begin":70,"end":82},"obj":"Disease"},{"id":"T6","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T7","span":{"begin":83,"end":94},"obj":"Disease"},{"id":"T8","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-deepseek-nr-ng","denotations":[{"id":"T1","span":{"begin":0,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gemini-nr-g","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gemini-r-g","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":119,"end":131},"obj":"Disease"},{"id":"T5","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gemini-r-ng","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid","denotations":[{"id":"T1","span":{"begin":6,"end":18},"obj":"Disease"},{"id":"T2","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T3","span":{"begin":19,"end":30},"obj":"Disease"},{"id":"T4","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T5","span":{"begin":70,"end":82},"obj":"Disease"},{"id":"T6","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T7","span":{"begin":83,"end":94},"obj":"Disease"},{"id":"T8","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gemini-nr-ng","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gpt-r-g","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gpt-nr-ng","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gpt-r-ng","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gpt-nr-g","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-deepseek-r-ng","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gemini-r-m","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gpt-r-m2","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-deepseek-r-g","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-deepseek-nr-g","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-deepseek-r-m","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}

{"project":"bc5cdr-valid-gpt-r-m","denotations":[{"id":"T1","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":70,"end":94},"obj":"Disease"},{"id":"T4","span":{"begin":135,"end":151},"obj":"Chemical"}],"text":"Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.\nHaemorrhagic myocarditis is a rare but important complication of cyclophosphamide therapy. Echocardiographic identification of the disorder can be made. We believe that the ultrasound features of this disorder have not been previously reported."}